Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Vanda Pharmaceuticals (VNDA) Depreciation Expense (2017 - 2025)

Vanda Pharmaceuticals (VNDA) has disclosed Depreciation Expense for 9 consecutive years, with $304000.0 as the latest value for Q4 2025.

  • Quarterly Depreciation Expense rose 37.56% to $304000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, up 28.41% year-over-year, with the annual reading at $1.1 million for FY2025, 28.41% up from the prior year.
  • Depreciation Expense hit $304000.0 in Q4 2025 for Vanda Pharmaceuticals, up from $301000.0 in the prior quarter.
  • In the past five years, Depreciation Expense ranged from a high of $345000.0 in Q1 2021 to a low of $185000.0 in Q4 2023.
  • Historically, Depreciation Expense has averaged $271250.0 across 5 years, with a median of $279000.0 in 2022.
  • Biggest five-year swings in Depreciation Expense: tumbled 33.11% in 2023 and later surged 39.35% in 2025.
  • Year by year, Depreciation Expense stood at $337000.0 in 2021, then fell by 20.77% to $267000.0 in 2022, then plummeted by 30.71% to $185000.0 in 2023, then grew by 19.46% to $221000.0 in 2024, then soared by 37.56% to $304000.0 in 2025.
  • Business Quant data shows Depreciation Expense for VNDA at $304000.0 in Q4 2025, $301000.0 in Q3 2025, and $267000.0 in Q2 2025.